IWM
PBYI icon

IHT Wealth Management’s Puma Biotechnology PBYI Stock Holding History

IHT Wealth Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-70
Closed -$5K – 1073
2018
Q1 		$5K Hold
70
– – ﹤0.01% 1345
2017
Q4 		$6K Sell
70
-73
-51% -$8.17K ﹤0.01% 1302
2017
Q3 		$17K Sell
143
-37
-21% -$3.44K 0.01% 822
2017
Q2 		$1K Hold
180
– – ﹤0.01% 1342
2017
Q1 		$6K Hold
180
– – ﹤0.01% 931
2016
Q4 		$6K Buy
+180
New +$7.78K ﹤0.01% 888

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

IHT Wealth Management's PBYI Position: Q2 2018 in Review

IHT Wealth Management sold out of Puma Biotechnology (PBYI) in Q2 2018, closing a stake of 70 shares — an estimated $5K sold.

IHT Wealth Management first reported a position in PBYI in Q4 2016 and held it in 6 quarters. The position peaked at $17K in Q3 2017. 174 funds tracked by Wall St. Rank hold PBYI as of Q2 2018.

  • IHT Wealth Management reported no remaining Puma Biotechnology position as of Q2 2018 after selling out during the quarter.
  • IHT Wealth Management sold 70 Puma Biotechnology shares in Q2 2018, an estimated $5K.
  • IHT Wealth Management first reported a position in Puma Biotechnology in Q4 2016 and held it in 6 quarters.
  • IHT Wealth Management's Puma Biotechnology position peaked at $17K in Q3 2017.
  • 174 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.